Asthma Exacerbations
A retrospective cohort study published in the Journal of Asthma and Allergy evaluates the real-world effectiveness of the drug tezepelumab. The research focuses on asthma exacerbations, healthcare utilization, and associated costs.
Why it matters
Clinical research on asthma treatments is vital for improving patient outcomes and managing the economic burden of chronic respiratory diseases.
Open access to scientific and medical research
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is a member of the OAI.
Bulk reprints for the pharmaceutical industry.
We offer real benefits to our authors, including fast-track processing of papers.
Back to Journals Journal of Asthma and Allergy Volume 19
Authors Zuluaga Sanchez S , DeMartino JK , Gorritz M , Ambrose CS , Tuly R , Llanos JP , Chen CC , Lindsley AW , Baylis L , Soong W , Tan L
Accepted for publication 20 September 2026
Published 3 October 2026 Volume 2026:19 620862
Editor who approved publication: Dr Amrita Dosanjh
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in